TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,183,000 | -81.9% | 55,593 | -93.5% | 0.00% | -80.0% |
| Q1 2022 | $23,128,000 | -43.8% | 861,406 | -0.1% | 0.02% | -9.1% |
| Q4 2021 | $41,122,000 | -28.6% | 862,075 | -0.5% | 0.02% | -31.2% |
| Q3 2021 | $57,582,000 | -14.4% | 866,823 | +0.5% | 0.03% | -11.1% |
| Q2 2021 | $67,283,000 | -12.0% | 862,398 | +6.6% | 0.04% | -7.7% |
| Q1 2021 | $76,501,000 | -22.6% | 808,762 | -0.3% | 0.04% | -18.8% |
| Q4 2020 | $98,864,000 | +103.6% | 811,362 | +46.0% | 0.05% | +60.0% |
| Q3 2020 | $48,551,000 | +35.0% | 555,758 | -0.2% | 0.03% | +15.4% |
| Q2 2020 | $35,972,000 | +121.9% | 556,929 | +53.4% | 0.03% | +85.7% |
| Q1 2020 | $16,209,000 | +25.3% | 362,941 | +74.8% | 0.01% | +55.6% |
| Q4 2019 | $12,937,000 | – | 207,682 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |